-
Read more: MMG Launches Patient Orientation Meetings to Help Access Faster Treatment in EuropeMMG has launched new free 15-minute Orientation Meetings in partnership with Manchester healthcare specialists CallCare to help UK patients navigate private treatment abroad. The sessions guide patients through diagnostics, treatment selection, finance options and booking surgery in Europe within six weeks of diagnostic clearance. Designed for patients facing long NHS waits and rising UK private…
-
Read more: MMG Partners with Spain’s HM Hospitales to Offer Faster, Lower-Cost Treatment for UK PatientsUK patients are increasingly looking overseas for faster and more affordable private medical treatment as NHS waiting lists remain near record levels and private hospital costs continue to rise across Britain. For many patients requiring orthopaedic surgery, spinal procedures, cardiology treatment or specialist diagnostics, the combination of long delays and escalating prices has created growing…
-
Read more: Skip the Queue, Choose the Surgeon: MMG’s Accredited European SpecialistsIf you are searching for private treatment in the UK, one critical question is often overlooked: who will perform your surgery? This blog explores the world-class surgeons leading MMG’s European hospitals, many with international training, high surgical volumes and extensive research credentials. It also explains why UK patients, often given little visibility over their surgeon,…
-
Read more: Skip the NHS Queue: The Five Orthopaedic Treatments Driving UK Patients to EuropeIf you’re searching for private treatment in the UK, you’re likely facing high costs and long waits. This blog explains why thousands of patients are now choosing Europe for the five most in-demand orthopaedic procedures, including knee, hip and spinal surgery. With significantly lower prices and the ability to secure surgery dates within weeks, MMG…
-
Read more: Why Europe’s Leading Hospitals Are Joining MMG to Serve UK PatientsThis guide is written for hospitals and clinics looking to attract UK private patients through a structured, scalable route. It explains how MMG’s accreditation process works, what is required to join the platform and how providers can position themselves competitively against UK private healthcare pricing. For hospitals ready to expand internationally, it sets out a…
-
7.2 million on NHS Waiting Lists: Why More Patients Are Choosing Affordable Private Treatment Abroad
Read more: 7.2 million on NHS Waiting Lists: Why More Patients Are Choosing Affordable Private Treatment AbroadFacing long NHS waiting lists and high private treatment costs in the UK, many patients are now exploring faster, more affordable options abroad. With NHS delays affecting millions and private surgery often costing £15,000 or more, accessing high-quality care in Europe is becoming an increasingly practical solution. Patients can benefit from shorter waiting times, transparent…
-
Read more: Palantir and the NHS: Data Can’t Fix a Capacity CrisisPalantir’s £330m NHS data contract promises efficiency, but has it reduced waiting lists? This analysis examines the Federated Data Platform, NHS digital inefficiencies and real waiting list trends. Despite claims of improved performance, evidence suggests only marginal impact. With NHS waiting lists still around 7.2 million cases, likely closer to 9 million, capacity constraints.- not…
-
Read more: NHS Waiting List Manipulation Concerns GrowThe NHS has quietly abandoned plans to cut GP referrals to hospitals by 25 per cent following widespread backlash, raising serious questions about how waiting list figures are being managed. With the NHS waiting list officially at 7.2 million cases, but likely closer to 9 million, the shift toward limiting referrals and expanding “advice and…
-
Read more: How MMG Chooses its Hospitals
When UK patients consider treatment abroad, the first question is not price. It is trust. Who is providing the care, and can it be relied upon? That question sits at the centre of My Medical Gateway’s model. Every hospital on the platform has passed through a structured, rigorous accreditation and onboarding process designed to ensure…
-
Read more: The Five Treatments Breaking the NHS – And the European SolutionThe NHS is under sustained pressure where it matters most: high-volume orthopaedic procedures that directly affect mobility, independence and the ability to work. Knee, hip, shoulder, spine and ACL treatments sit at the centre of this challenge. The data shows long waits, high private costs and limited domestic capacity. It also shows something else: immediate,…